Zhizhen Barbara Zheng,Stanley D'Andrea,Stanley DAndrea
申请号：
US13651538
公开号：
US08716275B2
申请日:
2012.10.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention provides (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1 -methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl) carbonyl)-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide (formula I), including pharmaceutically acceptable salts, as well as compositions and methods of using the compound. The compound has activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
